Operating Income - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98% Market Closed
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Operating Income
-$48.3m
CAGR 3-Years
-63%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.5B
CAGR 3-Years
-12%
CAGR 5-Years
13%
CAGR 10-Years
16%
Danaher Corp
NYSE:DHR
Operating Income
$4.7B
CAGR 3-Years
-11%
CAGR 5-Years
10%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.6B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
37%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
23%
CAGR 5-Years
20%
CAGR 10-Years
14%

See Also

What is MaxCyte Inc's Operating Income?
Operating Income
-48.3m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Operating Income amounts to -48.3m USD.

What is MaxCyte Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-42%

Over the last year, the Operating Income growth was -77%. The average annual Operating Income growth rates for MaxCyte Inc have been -63% over the past three years , -42% over the past five years .

Back to Top